Researchers test mRNA technology for universal flu vaccine
An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.
The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer PFE.N with BioNTech 22UAy.DE, and by Moderna MRNA.O. It delivers tiny lipid particles containing mRNA instructions for cells to create replicas of so-called hemagglutinin proteins that appear on influenza virus surfaces.
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
"The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs," study leader Scott Hensley of the Perelman School of Medicine at the University of Pennsylvania said in a statement.
Unlike standard flu vaccines that deliver one or two versions of hemagglutinin, the experimental vaccine includes 20 different types in the hope of getting the immune system to recognize any flu virus it might encounter in the future.
In lab experiments, vaccinated animals' immune systems recognized the hemagglutinin proteins and defended against 18 different strains of influenza A and two strains of influenza B. Antibody levels induced by the vaccine remained unchanged for at least four months, according to a report published in the journal Science.
The vaccine reduced signs of illness and protected from death even when the ferrets were exposed to a different type of flu not in the vaccine, the researchers said.
Moderna and Pfizer both have mRNA flu vaccines in late-stage human trials, and GSK GSK.L and partner CureVac 5CV.DE are testing an mRNA flu vaccine in an early-stage safety trial in humans. These vaccines are designed to defend against only four recently-circulating influenza strains but could theoretically be changed up each year.
The universal flu vaccine, if successful in human trials, would not necessarily prevent infection. The goal is to provide durable protection against severe disease and death, Hensley said.
Questions remain regarding how to judge efficacy and potential regulatory requirements for a vaccine against possible future viruses that are not currently circulating, Alyson Kelvin and Darryl Falzarano of the University of Saskatchewan, Canada, wrote in a commentary published with the study.
While the promising results with the new vaccine "suggest a protective capacity against all subtypes of influenza viruses, we cannot be sure until clinical trials in volunteers are done," Adolfo García-Sastrem, director of the Institute for Global Health and Emerging Pathogens at Mount Sinai Hospital in New York, said in a statement.
Reporting by Nancy Lapid; Editing by Christine Soares and Bill Berkrot
COVID-19 COVERAGE
CTVNews.ca Top Stories
BREAKING | Hockey Hall of Famer Bobby Hull dies at 84
Hockey Hall of Famer Bobby Hull has died at the age of 84. He played for the NHL's Chicago Blackhawks and Hartford Whalers as well as the World Hockey Association's Winnipeg Jets over a 23-year pro career.

Girl, 6, dead after accident at ski resort north of Montreal on Sunday
A six-year-old girl died in hospital Sunday night after being involved in an incident at the Val-Saint-Côme ski resort in Lanaudiere. Quebec police are investigating, though details into the event are not yet known. Officers indicated that it involved a T-bar lift, but they were not able to say more.
New alcohol recommendations could speed up changing drinking habits: businesses
Advocates and business owners in the beverage industry say new guidance for drinking alcohol could speed up changing consumer drinking habits as younger generations drink less and non-alcoholic beverages become more popular.
WHO: COVID-19 still an emergency but nearing 'inflection' point
The coronavirus remains a global health emergency, the World Health Organization chief said Monday, after a key advisory panel found the pandemic may be nearing an 'inflection point' where higher levels of immunity can lower virus-related deaths.
All countries 'dangerously unprepared' for future pandemics: report
The world is 'dangerously unprepared' for future pandemics, the International Federation of the Red Cross and Red Crescent Societies (IFRC) say in a report published on Monday, calling on countries to update their preparedness plans by year-end.
Are you a Ukrainian who recently moved to Canada? We want to hear from you
With Russia's invasion of Ukraine displacing millions of people, many refugees have begun to lay their roots in Canada. If you or someone you know has fled the war-torn country and settled in Canada, we want to hear from you.
NDP to call for emergency debate in House of Commons over private health care
Federal New Democrat Leader Jagmeet Singh says he will call on the House of Commons to hold an emergency debate on the privatization of health care.
COVID-19 global emergency isn't over: 5 things to know about the WHO decision
The World Health Organization decided Monday not to declare an end to the COVID-19 global public health emergency.
Quebec Cardinal Marc Ouellet set to retire after overseeing Vatican's bishops' office
Marc Ouellet, the Quebec cardinal who oversaw the Vatican's powerful bishops' office and has been recently accused of sexual misconduct, is retiring.